Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients

Journal of Periodontal Research

Volumn 47, Issue 6, 2012, Pages 681-688

  Konopka, L ^a   Pietrzak, A ^a   Brzezinska Blaszczyk E ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Interleukin 1 ; Interleukin 8; MMP 8; Scaling and root planing

Indexed keywords

AUTACOID; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE;

ARTICLE; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; TOOTH PLAQUE;

CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DENTAL SCALING; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; STATISTICS, NONPARAMETRIC;

EID: 84867231290     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2012.01480.x     Document Type: Article

References (55)

1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
2. Merchant AT & Pitiphat W. Researching periodontitis: challenges and opportunities. J Clin Periodontol 2007;34:1007-1015.
3. Bascones-Martínez A, Muñoz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain C, Campo-Trapero J. Host defence mechanisms against bacterial aggression in periodontal disease: basic mechanisms. Med Oral Patol Oral Cir Bucal 2009;14:680-685.
4. Ohlrich EJ, Cullinan MP, Seymour GJ. The immunopathogenesis of periodontal disease. Aust Dent J 2009;54(suppl 1):S2-S10.
5. Mombelli A. Clinical parameters: biological validity and clinical utility. Periodontol 2000 2005;39:30-39.
6. Armitage GC. Periodontal diseases: diagnosis. Ann Periodontol 1996;1:37-215.
7. Armitage GC. Analysis of gingival crevice fluid and risk of progression of periodontitis. Periodontol 2000 2004;34:109-119.
8. Lamster IB & Ahlo JK. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann NY Acad Sci 2007;1098:216-229.
9. Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin-1β, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res 2003;38:247-254.
10. Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1β concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-1463.
11. Ohshima M, Otsuka K, Suzuki K. Interleukin-lβ stimulates collagenase production by cultured human periodontal ligament fibroblasts. J Periodontal Res 1994;29:421-429.
12. Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993;64(suppl 5):456-460.
13. Jin LJ, Leung WK, Corbet EF, Söder B. Relationship of changes in interleukin-8 levels and granulocyte elastase activity in gingival crevicular fluid to subgingival periodontopathogens following non-surgical periodontal therapy in subjects with chronic periodontitis. J Clin Periodontol 2002;29:604-614.
14. Sorsa T, Tjäderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321.
15. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-318.
16. Kuula H, Salo T, Pirilä E et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 2009;77:850-859.
17. Hernández M, Gamonal J, Salo T et al. Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice. J Periodontal Res 2011;46:58-66.
18. Golub LM, Lee HM, Stoner JA et al. Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol 2008;79:1409-1418.
19. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1β, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000;71:1535-1545.
20. Rawlinson A, Dalati MH, Rahman S, Walsh TF, Fairclough AL. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 2000;27:738-743.
21. 2 and periodontal status in a community population. J Clin Periodontol 2007;34:285-293.
22. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-1β profiles in periodontal disease. J Clin Periodontol 2002;29:48-53.
23. Mäntylä P, Stenman M, Kinane DF et al. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res 2003;38:436-439.
24. Sorsa T, Mäntylä P, Rönkä H et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann NY Acad Sci 1999;878:130-140.
25. Kinane DF, Darby IB, Said S et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
26. Tsai CC, Ho YP, Chen CC. Levels of interleukin-1β and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 1995;66:852-859.
27. Mathur A, Michalowicz B, Castillo M, Aeppli D. Interleukin-1α, interleukin-8 and interferon-α levels in gingival crevicular fluid. J Periodontal Res 1996;31:489-495.
28. Chung RM, Grbíc JT, Lamster IB. Interleukin-8 and β-glucuronidase in gingival crevicular fluid. J Clin Periodontol 1997;24:146-152.
29. Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 2002;29(suppl 2):6-16.
30. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
31. Yücel OO, Berker E, Gariboǧlu S, Otlu H. Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008;35:365-370.
32. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1β and interleukin-10 levels in chronic periodontitis. J Dent 2004;32:511-520.
33. Toker H, Poyraz O, Eren K. Effect of periodontal treatment on IL-1β, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis. J Clin Periodontol 2008;35:507-513.
34. Yoshinari N, Kawase H, Mitani A et al. Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1β in gingival crevicular fluid and gingival tissues. J Periodontal Res 2004;39:158-167.
35. 2, IL-1β, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clin Biochem 2008;41:863-868.
36. 2 in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease. J Clin Periodontol 2006;33:605-611.
37. Hou LT, Liu CM, Rossomando EF. Crevicular interleukin-1β in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995;22:162-167.
38. Figueredo CM, Areas A, Miranda LA, Fischer RG, Gustafsson A. The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 2004;31:615-619.
39. Ingman T, Tervahartiala T, Ding Y et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996;23:1127-1132.
40. Passoja A, Ylipalosaari M, Tervonen T, Raunio T, Knuuttila M. Matrix metalloproteinase-8 concentration in shallow crevices associated with the extent of periodontal disease. J Clin Periodontol 2008;35:1027-1031.
41. Chen HY, Cox SW, Eley BM, Mäntylä P, Rönkä H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000;27:366-369.
42. Pozo P, Valenzuela MA, Melej C et al. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. J Periodontal Res 2005;40:199-207.
43. Biyikoǧlu B, Buduneli N, Kardeşler L, Aksu K, Pitkala M, Sorsa T. Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease. J Periodontol 2009;80:1307-1314.
44. Kardeşler L, Biyikoǧlu B, Cetinkalp S, Pitkala M, Sorsa T, Buduneli N. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics. Oral Dis 2010;16:476-481.
45. Marcaccini AM, Meschiari CA, Zuardi LR et al. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol 2010;37:180-190.
46. Sorsa T, Mäntylä P, Tervahartiala T, Pussinen PJ, Gamonal J, Hernandez M. MMP activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol 2011;38:817-819.
47. Sorsa T, Tervahartiala T, Leppilahti J et al. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 2011;63:108-113.
48. Gursoy UK, Könönen E, Pradhan-Palikhe P et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010;37:487-493.
49. Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis 2010;16:39-45.
50. Hernández M, Gamonal J, Tervahartiala T et al. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J Periodontol 2010;81:1644-1652.
51. Gursoy UK, Könönen E, Pussinen PJ et al. Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers 2011;30:299-305.
52. 2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 1996;67:755-762.
53. 2 and interleukin-1β levels following initial periodontal treatment and short-term meloxicam administration. Expert Opin Pharmacother 2010;11:1805-1812.
54. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002;73:103-109.
55. Serino G, Rosling B, Ramberg P, Socransky SS, Lindhe J. Initial outcome and long-term effect of surgical and non-surgical treatment of advanced periodontal disease. J Clin Periodontol 2001;28:910-916.